- Home
- KSCP vs PRLD Comparison
KSCP vs PRLD Comparison
Compare KSCP & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KSCP | PRLD |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 529.1M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KSCP | PRLD |
|---|---|---|
| Price | $0.98 | $4.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.00 | $5.67 |
| AVG Volume (30 Days) | ★ 724.8K | 404.6K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.54 | 23.21 |
| EPS | N/A | ★ N/A |
| Revenue | $11,335,000.00 | ★ $12,140,000.00 |
| Revenue This Year | $218.66 | $320.10 |
| Revenue Next Year | $54.32 | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.91 | ★ 73.43 |
| 52 Week Low | $1.00 | $1.15 |
| 52 Week High | $7.62 | $6.83 |
Technical Indicators
Market Signals| Indicator | KSCP | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 27.91 | 44.44 |
| Support Level | N/A | $3.92 |
| Resistance Level | $2.15 | $5.23 |
| Average True Range (ATR) | 0.09 | 0.29 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 11.65 | 34.52 |
Price Performance
Historical ComparisonAbout KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.